End-of-day quote
Shenzhen S.E.
23:00:00 26/06/2024 BST
|
5-day change
|
1st Jan Change
|
1.34
CNY
|
-2.19%
|
|
-12.99%
|
-51.09%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,553
|
4,875
|
2,089
|
8,979
|
4,499
|
5,356
|
Enterprise Value (EV)
1 |
6,372
|
5,650
|
2,819
|
9,437
|
4,856
|
5,546
|
P/E ratio
|
-26.8
x
|
-17.3
x
|
37
x
|
-18.3
x
|
-239
x
|
-68.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
9.2
x
|
11.3
x
|
5.04
x
|
26.4
x
|
14.9
x
|
16.2
x
|
EV / Revenue
|
10.6
x
|
13.1
x
|
6.8
x
|
27.8
x
|
16.1
x
|
16.8
x
|
EV / EBITDA
|
37.2
x
|
38.6
x
|
25.4
x
|
775
x
|
-50.4
x
|
-286
x
|
EV / FCF
|
-26.8
x
|
-16.3
x
|
141
x
|
-15
x
|
-25.6
x
|
-20.9
x
|
FCF Yield
|
-3.73%
|
-6.13%
|
0.71%
|
-6.68%
|
-3.91%
|
-4.77%
|
Price to Book
|
2.87
x
|
2.96
x
|
1.25
x
|
7.39
x
|
3.74
x
|
4.19
x
|
Nbr of stocks (in thousands)
|
1,882,412
|
1,882,412
|
1,882,412
|
1,882,412
|
1,882,412
|
1,954,589
|
Reference price
2 |
2.950
|
2.590
|
1.110
|
4.770
|
2.390
|
2.740
|
Announcement Date
|
25/04/19
|
23/04/20
|
28/04/21
|
30/03/22
|
11/04/23
|
29/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
603.6
|
431.3
|
414.5
|
339.9
|
301.3
|
331.1
|
EBITDA
1 |
171.2
|
146.5
|
110.8
|
12.18
|
-96.38
|
-19.42
|
EBIT
1 |
81.1
|
58.72
|
25.23
|
-46.35
|
-140.2
|
-67.34
|
Operating Margin
|
13.43%
|
13.62%
|
6.09%
|
-13.64%
|
-46.54%
|
-20.34%
|
Earnings before Tax (EBT)
1 |
-217.3
|
-268.8
|
56.58
|
-503.1
|
-8.057
|
-76.29
|
Net income
1 |
-203.5
|
-275.2
|
55.64
|
-496.9
|
-22.68
|
-84.82
|
Net margin
|
-33.71%
|
-63.81%
|
13.43%
|
-146.19%
|
-7.53%
|
-25.62%
|
EPS
2 |
-0.1100
|
-0.1500
|
0.0300
|
-0.2600
|
-0.0100
|
-0.0400
|
Free Cash Flow
1 |
-237.4
|
-346.3
|
20.06
|
-630.6
|
-189.8
|
-264.8
|
FCF margin
|
-39.34%
|
-80.3%
|
4.84%
|
-185.54%
|
-62.99%
|
-79.97%
|
FCF Conversion (EBITDA)
|
-
|
-
|
18.1%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
36.05%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/04/19
|
23/04/20
|
28/04/21
|
30/03/22
|
11/04/23
|
29/04/24
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-36.16
|
Net margin
|
-
|
EPS
2 |
-0.0200
|
Dividend per Share
|
-
|
Announcement Date
|
27/04/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
819
|
775
|
730
|
458
|
357
|
191
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.787
x
|
5.288
x
|
6.589
x
|
37.62
x
|
-3.701
x
|
-9.818
x
|
Free Cash Flow
1 |
-237
|
-346
|
20.1
|
-631
|
-190
|
-265
|
ROE (net income / shareholders' equity)
|
-10.2%
|
-15.3%
|
3.25%
|
-34%
|
-2.21%
|
-6.58%
|
ROA (Net income/ Total Assets)
|
1.46%
|
1.26%
|
0.57%
|
-1.19%
|
-4.32%
|
-2.22%
|
Assets
1 |
-13,976
|
-21,925
|
9,689
|
41,760
|
524.8
|
3,818
|
Book Value Per Share
2 |
1.030
|
0.8800
|
0.8900
|
0.6500
|
0.6400
|
0.6500
|
Cash Flow per Share
2 |
0.0400
|
0.0300
|
0.0300
|
0.0600
|
0.0800
|
0.0200
|
Capex
1 |
207
|
44.7
|
34
|
89.9
|
27.7
|
21.7
|
Capex / Sales
|
34.29%
|
10.36%
|
8.2%
|
26.45%
|
9.2%
|
6.55%
|
Announcement Date
|
25/04/19
|
23/04/20
|
28/04/21
|
30/03/22
|
11/04/23
|
29/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -51.09% | 368M | | +2.11% | 102B | | -11.98% | 58.85B | | +72.38% | 47.79B | | +8.17% | 36.9B | | +0.95% | 31.19B | | +4.85% | 18.85B | | +13.88% | 17.05B | | +5.77% | 13.95B | | -5.51% | 13.14B |
Other Commodity Chemicals
|